To determine whether FGF2 reduction is responsible for vasculopathy in diabetic pregnancy, we generated a transgenic (Tg) mouse line in which the Fgf2 open reading frame and a separate nuclear GFP were driven by the promoter of the embryonic endoderm marker transthyretin (TTR) (Supplementary Fig. 1). Here, TTR is linked to vascular disorder.